Work

TCT-281 Reasons for Less Than Maximal Target Doses of Heart Failure Medications in Patients Enrolled in the COAPT Trial

Year: 2021

Type: conference-abstract

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2021.09.1134

Authors: Sandip Zalawadiya, Zachary Cox, Matheus Simonato, Bjorn Redfors, Michael Zile, Scott Lim, Zhipeng Zhou, Lak Kotinkaduwa, Michael Mack, William Abraham, Gregg Stone, JoAnn Lindenfeld

Institutions: Vanderbilt University Medical Center, Lipscomb University, Cardiovascular Research Foundation, Medical University of South Carolina, University of Virginia Medical Center, University of Virginia, Heart Hospital Baylor Plano, The Ohio State University Wexner Medical Center, Vanderbilt University

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3210107292

Cites:

Cited by: 1

Related to: 10